<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2681217-A1" country="EP" doc-number="2681217" kind="A1" date="20140108" family-id="44079697" file-reference-id="252638" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146587049" ucid="EP-2681217-A1"><document-id><country>EP</country><doc-number>2681217</doc-number><kind>A1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-12707548-A" is-representative="NO"><document-id mxw-id="PAPP154849241" load-source="docdb" format="epo"><country>EP</country><doc-number>12707548</doc-number><kind>A</kind><date>20120302</date><lang>EN</lang></document-id><document-id mxw-id="PAPP220440256" load-source="docdb" format="original"><country>EP</country><doc-number>12707548.9</doc-number><date>20120302</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140551409" ucid="EP-11156721-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>11156721</doc-number><kind>A</kind><date>20110303</date></document-id></priority-claim><priority-claim mxw-id="PPC140552146" ucid="EP-12707548-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>12707548</doc-number><kind>A</kind><date>20120302</date></document-id></priority-claim><priority-claim mxw-id="PPC140548019" ucid="EP-2012053605-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>2012053605</doc-number><kind>W</kind><date>20120302</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1989320395" load-source="docdb">C07D 471/06        20060101AFI20120921BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989322383" load-source="docdb">H01L  51/00        20060101ALI20120921BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL1989620038" load-source="docdb" scheme="CPC">H01L  51/0545      20130101 LA20130820BHEP        </classification-cpc><classification-cpc mxw-id="PCL1989625527" load-source="docdb" scheme="CPC">C07D 471/06        20130101 FI20130820BHEP        </classification-cpc><classification-cpc mxw-id="PCL1989642378" load-source="docdb" scheme="CPC">H01L  51/0053      20130101 LI20130820BHEP        </classification-cpc><classification-cpc mxw-id="PCL1989653215" load-source="docdb" scheme="CPC">C09B   5/62        20130101 LI20130515BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132365780" lang="DE" load-source="patent-office">PERYLEN-BASIERTE HALBLEITERMATERIALIEN</invention-title><invention-title mxw-id="PT132365781" lang="EN" load-source="patent-office">PERYLENE-BASED SEMICONDUCTING MATERIALS</invention-title><invention-title mxw-id="PT132365782" lang="FR" load-source="patent-office">MATÉRIAUX SEMI-CONDUCTEURS À BASE DE PÉRYLÈNE</invention-title><citations><non-patent-citations><nplcit><text>See references of WO 2012117089A1</text><sources><source mxw-id="PNPL67456285" load-source="docdb" name="SEA"/></sources></nplcit></non-patent-citations></citations></technical-data><parties><applicants><applicant mxw-id="PPAR919514957" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>BASF SE</last-name><address><country>DE</country></address></addressbook></applicant><applicant mxw-id="PPAR919527679" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>BASF SE</last-name></addressbook></applicant><applicant mxw-id="PPAR919012737" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>BASF SE</last-name><iid>101298228</iid><address><city>67056 Ludwigshafen</city><country>DE</country></address></addressbook></applicant><applicant mxw-id="PPAR919541535" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>MAX PLANCK GESELLSCHAFT</last-name><address><country>DE</country></address></addressbook></applicant><applicant mxw-id="PPAR919524564" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.</last-name></addressbook></applicant><applicant mxw-id="PPAR919010664" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.</last-name><iid>100174034</iid><address><street>Hofgartenstrasse 8</street><city>80539 München</city><country>DE</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919515173" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>REICHELT HELMUT</last-name><address><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR919536695" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>REICHELT, HELMUT</last-name></addressbook></inventor><inventor mxw-id="PPAR919012264" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>REICHELT, HELMUT</last-name><address><street>Johann-Gottlieb-Fichte-Str.56</street><city>67435 Neustadt</city><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR919536890" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>GESNER THOMAS</last-name><address><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR919505677" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>GESNER, THOMAS</last-name></addressbook></inventor><inventor mxw-id="PPAR919010194" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>GESSNER, THOMAS</last-name><address><street>Gundolfstr.1</street><city>69120 Heidelberg</city><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR919520682" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>MUELLEN KLAUS</last-name><address><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR919510570" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>MUELLEN, KLAUS</last-name></addressbook></inventor><inventor mxw-id="PPAR919009258" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>MÜLLEN, Klaus</last-name><address><street>Geisbergstr. 139</street><city>50939 Köln</city><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR919546479" load-source="docdb" sequence="4" format="epo"><addressbook><last-name>LI CHEN</last-name><address><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR919529373" load-source="docdb" sequence="4" format="intermediate"><addressbook><last-name>LI, CHEN</last-name></addressbook></inventor><inventor mxw-id="PPAR919018932" load-source="patent-office" sequence="4" format="original"><addressbook><last-name>LI, CHEN</last-name><address><street>Hegelstrasse 58</street><city>55122 Mainz</city><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR919507650" load-source="docdb" sequence="5" format="epo"><addressbook><last-name>BATTAGLIARIN GLAUCO</last-name><address><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR919521451" load-source="docdb" sequence="5" format="intermediate"><addressbook><last-name>BATTAGLIARIN, Glauco</last-name></addressbook></inventor><inventor mxw-id="PPAR919016392" load-source="patent-office" sequence="5" format="original"><addressbook><last-name>BATTAGLIARIN, Glauco</last-name><address><street>Rheinallee 1d</street><city>55116 Mainz</city><country>DE</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR919009547" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Bernhardt, Wolfgang Willy-Hans</last-name><iid>101339535</iid><address><street>BASF Schweiz AG IP Department P.O. Box</street><city>4002 Basel</city><country>CH</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="EP-2012053605-W"><document-id><country>EP</country><doc-number>2012053605</doc-number><kind>W</kind><date>20120302</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2012117089-A1"><document-id><country>WO</country><doc-number>2012117089</doc-number><kind>A1</kind><date>20120907</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS549850465" load-source="docdb">AL</country><country mxw-id="DS549850229" load-source="docdb">AT</country><country mxw-id="DS549850498" load-source="docdb">BE</country><country mxw-id="DS549767883" load-source="docdb">BG</country><country mxw-id="DS549768190" load-source="docdb">CH</country><country mxw-id="DS549864750" load-source="docdb">CY</country><country mxw-id="DS549850238" load-source="docdb">CZ</country><country mxw-id="DS549848932" load-source="docdb">DE</country><country mxw-id="DS549850499" load-source="docdb">DK</country><country mxw-id="DS549864751" load-source="docdb">EE</country><country mxw-id="DS549780764" load-source="docdb">ES</country><country mxw-id="DS549767884" load-source="docdb">FI</country><country mxw-id="DS549767889" load-source="docdb">FR</country><country mxw-id="DS549850500" load-source="docdb">GB</country><country mxw-id="DS549850501" load-source="docdb">GR</country><country mxw-id="DS549850514" load-source="docdb">HR</country><country mxw-id="DS549864752" load-source="docdb">HU</country><country mxw-id="DS549768191" load-source="docdb">IE</country><country mxw-id="DS549850515" load-source="docdb">IS</country><country mxw-id="DS549767890" load-source="docdb">IT</country><country mxw-id="DS549864753" load-source="docdb">LI</country><country mxw-id="DS549848933" load-source="docdb">LT</country><country mxw-id="DS549850239" load-source="docdb">LU</country><country mxw-id="DS549848938" load-source="docdb">LV</country><country mxw-id="DS549848939" load-source="docdb">MC</country><country mxw-id="DS549917791" load-source="docdb">MK</country><country mxw-id="DS549917792" load-source="docdb">MT</country><country mxw-id="DS549780769" load-source="docdb">NL</country><country mxw-id="DS549767891" load-source="docdb">NO</country><country mxw-id="DS549780770" load-source="docdb">PL</country><country mxw-id="DS549767892" load-source="docdb">PT</country><country mxw-id="DS549780771" load-source="docdb">RO</country><country mxw-id="DS549768192" load-source="docdb">RS</country><country mxw-id="DS549780772" load-source="docdb">SE</country><country mxw-id="DS549768197" load-source="docdb">SI</country><country mxw-id="DS549917793" load-source="docdb">SK</country><country mxw-id="DS549917794" load-source="docdb">SM</country><country mxw-id="DS549864758" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><abstract mxw-id="PA99837288" ref-ucid="WO-2012117089-A1" lang="EN" load-source="patent-office"><p num="0000">The present invention provides a compound of formula The compound of formula (1) is suitable for use as semiconducting material, in particular in electronic devices.</p></abstract><abstract mxw-id="PA100333029" ref-ucid="WO-2012117089-A1" lang="EN" source="national office" load-source="docdb"><p>The present invention provides a compound of formula The compound of formula (1) is suitable for use as semiconducting material, in particular in electronic devices.</p></abstract><abstract mxw-id="PA99837289" ref-ucid="WO-2012117089-A1" lang="FR" load-source="patent-office"><p num="0000">La présente invention porte sur un composé représenté par la formule. Le composé représenté par la formule (1) est approprié pour être utilisé comme matériau semi-conducteur, en particulier dans des dispositifs électroniques.</p></abstract><abstract mxw-id="PA100333030" ref-ucid="WO-2012117089-A1" lang="FR" source="national office" load-source="docdb"><p>La présente invention porte sur un composé représenté par la formule. Le composé représenté par la formule (1) est approprié pour être utilisé comme matériau semi-conducteur, en particulier dans des dispositifs électroniques.</p></abstract><description mxw-id="PDES51233542" ref-ucid="WO-2012117089-A1" lang="EN" load-source="patent-office"><!-- EPO <DP n="2"/>--><p id="p0001" num="0001"> Perylene-based Semiconducting Materials </p><p id="p0002" num="0002">Description </p><p id="p0003" num="0003"> Organic semiconducting materials can be used in electronic devices such as organic photo- voltaic (OPV) cells, organic field-effect transistors (OFETs) and organic light emitting diodes (OLEDs). </p><p id="p0004" num="0004">For efficient and long lasting performance, it is desirable that the organic semiconducting material-based devices show high charge carrier mobility and high stability, in particular towards oxi- dation, under ambient conditions. </p><p id="p0005" num="0005">Furthermore, it is desirable that the organic semiconducting materials are compatible with liquid processing techniques as liquid processing techniques are convenient from the point of proc- essability, and thus allow the production of low cost organic semiconducting material-based electronic devices. In addition, liquid processing techniques are also compatible with plastic substrates, and thus allow the production of light weight and flexible organic semiconducting material-based electronic devices. </p><p id="p0006" num="0006">The use of perylene-based organic semiconducting materials in electronic devices is known in the art. </p><p id="p0007" num="0007">US 7,282,275 B2 describes a composition that includes </p><p id="p0008" num="0008"> a first compound of formula [EC-]<sub>n</sub>-Ar<sup>1</sup> (I), wherein </p><p id="p0009" num="0009"> A<sup>1</sup> is a first aromatic core and is a divalent, trivalent or tetravalent radical of a long list of formulae, including </p><p id="p0010" num="0010"><img id="imgf000002_0001" he="44" wi="22" file="imgf000002_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0011" num="0011">that is unsubstituted or substituted with a long list of substituents, including fluoro and cyano, </p><p id="p0012" num="0012">EC is a first end capping group and is a monovalent radical of a long list of formulae, n is an integer of 2 to 4 </p><p id="p0013" num="0013"> Z is NH or CH<sub>2</sub>, and 
<!-- EPO <DP n="3"/>-->
 a second compound having an aromatic radical that comprises the first aromatic core of the first compound, a second end capping group that comprises the first end capping group of the first compound, a divalent radical that comprises a divalent radical of the first end capping group, or a combination thereof, wherein the composition is amorphous and solution processible. </p><p id="p0014" num="0014">Also provided is an electronic device including the composition. </p><p id="p0015" num="0015">US 7,355,198 B2 describes am organic thin film transistor (OFET), which interposes an organic acceptor film between source and drain electrodes and an organic semiconductor film. The organic semiconductor film is formed of pentacene. In particular, the organic acceptor film is formed of at least one electron withdrawing material selected from a long list of compounds, including N,N'-bis(di-ferf-butyphenyl)-3,4,9,10-perylenedicarboxyimide. </p><p id="p0016" num="0016">US 7,326,956 B2 describes a thin film transitor comprising a layer of organic semiconductor material comprising tetracarboxylic diimide 3,4,9,10-perylene-based compound having attached to each of the imide nitrogen atoms a carbocyclic or heterocyclic aromatic ring system substituted with one or more fluorine containing groups. In one embodiment the fluorine-containing Ν,Ν'-diaryl perylene-based tetracarboxylic diimide compound is represented by the following structure: 1 </p><p id="p0017" num="0017"><img id="imgf000003_0001" he="48" wi="26" file="imgf000003_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 wherein A<sup>1</sup> and A<sup>2</sup> are independently carbocyclic and/or heterocyclic aromatic ring systems comprising at least one aromatic ring in which one or more hydrogen atoms are substituted with at least one fluorine-containing group. The perylene nucleus can be optionally substituted with up to eight independently selected X groups, wherein n is an integer from 0 to 8. The X sub- stituent groups on the perylene can include a long list of substituents, including halogens such as fluorine or chlorine, and cyano. 
<!-- EPO <DP n="4"/>-->
 US 7,671 ,202 B2 describes n-type semiconductor compounds of formula </p><p id="p0018" num="0018"><img id="imgf000004_0001" he="48" wi="33" file="imgf000004_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 wherein each R<sup>1</sup> to R<sup>8</sup>, R<sup>11</sup> and R<sup>12</sup> can be independently selected from H, an electron- withdrawing substituent and a moiety comprising such substituent. Electron-withdrawing substi- tutents include a long list of substituents, including cyano. R<sup>9</sup> and R<sup>10</sup> are independently selected from H, alkyi, substituted alkyi, cycloalkyi, substituted cycloalkyi, aryl, substituted aryl, polycyclic aryl and/or substituted polycyclic aryl moieties. At least one of R<sup>1</sup>, R<sup>4</sup>, R<sup>5</sup>, R<sup>8</sup>, R<sup>11</sup> and R<sup>12</sup> can be a cyano substituent. Such cyanated compounds can be di- or tetra-substituted as shown by the following structures: </p><p id="p0019" num="0019"><img id="imgf000004_0002" he="62" wi="151" file="imgf000004_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0020" num="0020">WO 2005/124453 describes perylenetetracarboxylic diimide charge-transfer materials, for example a perylenetetracarboxylic diimide charge-transfer material having formula 
<!-- EPO <DP n="5"/>-->
 
<img id="imgf000005_0001" he="49" wi="30" file="imgf000005_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 wherein Y in each instance can be independently selected from H, CN, acceptors, donors and a polymerizable group; and X in each instance can be independently selected from a large group of listed compounds. </p><p id="p0021" num="0021">WO 2008/063609 describes diimide-based semiconductor compounds. In a particular embodi- ment the compound can have formula </p><p id="p0022" num="0022"><img id="imgf000005_0002" he="55" wi="87" file="imgf000005_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 wherein R<sup>1</sup> at each occurrence is independently selected from a long list of groups, including branched C<sub>3</sub>-2o-alkyl and branched C<sub>3</sub>-2o-alkenyl. 
<!-- EPO <DP n="6"/>-->
</p><p id="p0023" num="0023">WO 2009/098252 describes semiconducting compounds having formula </p><p id="p0024" num="0024"><img id="imgf000006_0001" he="60" wi="33" file="imgf000006_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 wherein R<sup>1</sup> and R<sup>2</sup> at each occurrence independently are selected from a large list of groups, including H, Ci-30-alkyl and C2-3o-alkenyl; and R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup> and R<sup>6</sup> are independently H or an electron-withdrawing group. In certain embodiments, at least one of R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup> and R<sup>6</sup> can be Br or cyano. For example, the semiconducting compound can include </p><p id="p0025" num="0025"><img id="imgf000006_0002" he="56" wi="34" file="imgf000006_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0026" num="0026">WO 2009/144205 describes bispolycyclic rylene-based semiconducting materials, for example </p><p id="p0027" num="0027"><img id="imgf000006_0003" he="57" wi="81" file="imgf000006_0003.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="yes"/><!-- EPO <DP n="7"/>-->
 S. Nakanzono, S. Easwaramoorthi, D. Kim, H. Shinokubo, A. Osuka Org. Lett. 2009, 11, 5426 to 5429 describes the preparation of 2,5,8,1 1 tetraarylated perylene tetracaroxylic acid bisim- ides from perylene tetracarboxylic acid bisimides </p><p id="p0028" num="0028"><img id="imgf000007_0001" he="54" wi="116" file="imgf000007_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0029" num="0029">It was the object of the present invention to provide new perylene-based semiconducting materials. </p><p id="p0030" num="0030">The object is solved by the compound of claim 1 , the process of claim 2, the compound of claim 6, and the electronic device of claim 7. </p><p id="p0031" num="0031">The perylene-based semiconducting compound of the present invention is of formula 1 </p><p id="p0032" num="0032"><img id="imgf000007_0002" he="49" wi="50" file="imgf000007_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0033" num="0033">wherein </p><p id="p0034" num="0034"> R<sup>1</sup> and R<sup>2</sup> are independently selected from the group consisting of H, Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, 3-14 membered cycloheteroalkyl, C6-i4-aryl and 5-14 membered heteroaryl, 
<!-- EPO <DP n="8"/>-->
 wherein if R<sup>1</sup> or R<sup>2</sup> are Ci-30-alkyl, C<sub>2</sub>-3o-alkenyl or C<sub>2</sub>-3o-alkynyl, this R<sup>1</sup> or R<sup>2</sup> can be optionally substituted with 1 to 6 groups independently selected from the group consisting of halogen, -CN , -NO2, -OH , Ci-10-alkoxy, -O-CH<sub>2</sub>CH<sub>2</sub>O-Ci-i<sub>0</sub>-alkyl, -O-COR<sup>3</sup>, -S-Ci-io-alkyl, -N H<sub>2</sub>, -N H R<sup>3</sup>,</p><p id="p0035" num="0035">-N R3R<sup>4</sup>, -N H-COR<sup>3</sup>, -COOH , -COOR<sup>3</sup>, -CON H2, -CO N H R<sup>3</sup>, -CON R<sup>3</sup>R<sup>4</sup>, -CO-H , -COR<sup>3</sup>, C3-io-cycloalkyl, 3-14 membered cycloheteroalkyl, C6-i<sub>4</sub>-aryl and 5-14 membered heteroaryl; if R<sup>1</sup> or R<sup>2</sup> are C3-io-cycloalkyl, Cs-io-cycloalkenyl or 3-14 membered cycloheteroalkyl, this R<sup>1</sup> or R<sup>2</sup> can be optionally substituted with 1 to 6 groups independently selected from the group consisting of halogen, -CN , -NO2, -OH , Ci-io-alkoxy, -O-CH<sub>2</sub>CH<sub>2</sub>O-Ci-i<sub>0</sub>-alkyl, -O-COR<sup>3</sup>, -S-Ci-io-alkyl, -N H<sub>2</sub>, -N H R<sup>3</sup>, -N R<sup>3</sup>R<sup>4</sup>, -N H-COR<sup>3</sup>, -COOH , -COOR<sup>3</sup>, -CON H<sub>2</sub>, -CO N H R<sup>3</sup>, -CON R<sup>3</sup>R<sup>4</sup>, -CO-H , -COR<sup>3</sup>, Ci-io-alkyl, C<sub>2</sub>-io-alkenyl, C<sub>2</sub>-io-alkynyl, C<sub>6</sub>-i<sub>4</sub>-aryl and 5-14 membered heteroaryl; if R<sup>1</sup> or R<sup>2</sup> are C6-i<sub>4</sub>-aryl or 5-14 membered heteroaryl, this R<sup>1</sup> or R<sup>2</sup> can be optionally substituted with 1 to 6 groups independently selected from the group consisting of halogen, -CN , -NO2, -OH , Ci-io-alkoxy, -O-CH<sub>2</sub>CH<sub>2</sub>O-Ci-i<sub>0</sub>-alkyl, -O-COR<sup>3</sup>, -S-Ci-io-alkyl, -N H<sub>2</sub>, -N H R<sup>3</sup>, -N R<sup>3</sup>R<sup>4</sup>, -N H-COR<sup>3</sup>, -COOH , -COOR<sup>3</sup>, -CON H<sub>2</sub>, -CO N H R<sup>3</sup>, -CON R<sup>3</sup>R<sup>4</sup>, -CO-H , -COR<sup>3</sup>, Ci-10-alkyl, C<sub>2</sub>-io-alkenyl, C<sub>2</sub>-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl and 3-14 membered cycloheteroalkyl, wherein R<sup>3</sup> and R<sup>4</sup> are at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C<sub>2</sub>-io-alkenyl, C<sub>2</sub>-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, 3-14 membered cycloheteroalkyl, C6-i<sub>4</sub>-aryl and 5-14 membered heteroaryl. </p><p id="p0036" num="0036">Ci-10-alkyl and Ci-30-alkyl can be branched or unbranched. Examples of Ci-10-alkyl are methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, ferf-butyl, n-pentyl, neopentyl, isopentyl, n-(1 -ethyl)propyl, n-hexyl, n-heptyl, n-octyl, n-(2-ethyl)hexyl, n-nonyl and n-decyl. Examples of C3-8-alkyl are n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, ferf-butyl, n-pentyl, neopentyl, isopentyl, n-(1 -ethyl)propyl, n-hexyl, n-heptyl, n-octyl and n-(2-ethyl)hexyl. Examples of Ci-3o-alkyl are Ci-10-alkyl, and n-undecyl, n-dodecyl, n-undecyl, n-dodecyl, n-tridecyl, </p><p id="p0037" num="0037">n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20), n-docosyl (C<sub>22</sub>), n-tetracosyl (C<sub>24</sub>), n-hexacosyl (0¾), n-octacosyl (C<sub>2</sub>e) and n-triacontyl </p><p id="p0038" num="0038">C<sub>2</sub>-io-alkenyl and C<sub>2</sub>-3o-alkenyl can be branched or unbranched. Examples of C<sub>2</sub>-io-alkenyl are vinyl, propenyl, c/s-2-butenyl, frans-2-butenyl, 3-butenyl, c/s-2-pentenyl, frans-2-pentenyl, c/s-3-pentenyl, frans-3-pentenyl, 4-pentenyl, 2-methyl-3-butenyl, hexenyl, heptenyl, octenyl, 
<!-- EPO <DP n="9"/>-->
 nonenyl and docenyl. Examples of C2-3o-alkenyl are C2-io-alkenyl, and linoleyl (Cie), linolenyl (Cie), oleyl (Cie), arachidonyl (C20), and erucyl (C22). </p><p id="p0039" num="0039">C2-io-alkynyl and C2-3o-alkynyl can be branched or unbranched. Examples of C2-io-alkynyl are ethynyl, 2-propynyl, 2-butynyl, 3-butynyl, pentynyl, hexynyl, heptynyl, octynyl, nonynyl and de- cynyl. Examples of C2-3o-alkynyl are C2-io-alkynyl, and undecynyl, dodecynyl, undecynyl, dode- cynyl, tridecynyl, tetradecynyl, pentadecynyl, hexadecynyl, heptadecynyl, octadecynyl, nonade- cynyl and icosynyl (C20). Examples of C3-io-cycloalkyl are preferably monocyclic C3-io-cycloalkyls such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl, but include also polycyclic C3-io-cycloalkyls such as decalinyl, norbornyl and adamantyl. </p><p id="p0040" num="0040">Examples of Cs-io-cycloalkenyl are preferably monocyclic Cs-io-cycloalkenyls such as cyclopen- tenyl, cyclohexenyl, cyclohexadienyl and cycloheptatrienyl, but include also polycyclic </p><p id="p0041" num="0041">Cs-io-cycloalkenyls. </p><p id="p0042" num="0042">Examples of 3-14 membered cycloheteroalkyi are monocyclic 3-8 membered cycloheteroalkyi and polycyclic, for example bicyclic 7-12 membered cycloheteroalkyi. </p><p id="p0043" num="0043">Examples of monocyclic 3-8 membered cycloheteroalkyi are monocyclic 5 membered cycloheteroalkyi containing one heteroatom such as pyrrolidinyl, 1 -pyrrolinyl, 2-pyrrolinyl, 3-pyrrolinyl, tetrahydrofuryl, 2,3-dihydrofuryl, tetrahydrothiophenyl and 2,3-dihydrothiophenyl, monocyclic</p><p id="p0044" num="0044">5 membered cycloheteroalkyi containing two heteroatoms such as imidazolidinyl, imidazolinyl, pyrazolidinyl, pyrazolinyl, oxazolidinyl, oxazolinyl, isoxazolidinyl, isoxazolinyl, thiazolidinyl, thia- zolinyl, isothiazolidinyl and isothiazolinyl, monocyclic 5 membered cycloheteroalkyi containing three heteroatoms such as 1 ,2,3-triazolyl, 1 ,2,4-triazolyl and 1 ,4,2-dithiazolyl, monocyclic</p><p id="p0045" num="0045">6 membered cycloheteroalkyi containing one heteroatom such as piperidyl, piperidino, tetrahy- dropyranyl, pyranyl, thianyl and thiopyranyl, monocyclic 6 membered cycloheteroalkyi contain- ing two heteroatoms such as piperazinyl, morpholinyl and morpholino and thiazinyl, monocyclic</p><p id="p0046" num="0046">7 membered cycloheteroalkyi containing one hereoatom such as azepanyl, azepinyl, oxepanyl, thiepanyl, thiapanyl, thiepinyl, and monocyclic 7 membered cycloheteroalkyi containing two hereoatom such as 1 ,2-diazepinyl and 1 ,3-thiazepinyl. An example of a bicyclic 7-12 membered cycloheteroalkyi is decahydronaphthyl. </p><p id="p0047" num="0047">C6-i4-aryl can be monocyclic or polycyclic. Examples of C6-i4-aryl are monocyclic C6-aryl such as phenyl, bicyclic Cg-io-aryl such as 1 -naphthyl, 2-naphthyl, indenyl, indanyl and tetrahy- dronaphthyl, and tricyclic Ci2-i4-aryl such as anthryl, phenanthryl, fluorenyl and s-indacenyl. 
<!-- EPO <DP n="10"/>-->
 5-14 membered heteroaryl can be monocyclic 5-8 membered heteroaryl, or polycyclic 7-14 membered heteroaryl, for example bicyclic 7-12 membered or tricyclic 9-14 membered heteroaryl. Examples of monocyclic 5-8 membered heteroaryl are monocyclic 5 membered heteroaryl containing one heteroatom such as pyrrolyl, furyl and thiophenyl, monocyclic 5 membered heteroaryl containing two heteroatoms such as imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, monocyclic 5 membered heteroaryl containing three heteroatoms such as 1 ,2,3- triazolyl, 1 ,2,4-triazolyl and oxadiazolyl, monocyclic 5 membered heteroaryl containing four het- eroatoms such as tetrazolyl, monocyclic 6 membered heteroaryl containing one heteroatom such as pyridyl, monocyclic 6 membered heteroaryl containing two heteroatoms such as pyraz- inyl, pyrimidinyl and pyridazinyl, monocyclic 6 membered heteroaryl containing three heteroatoms such as 1 ,2,3-triazinyl, 1 ,2,4-triazinyl and 1 ,3,5-triazinyl, monocyclic 7 membered heteroaryl containing one heteroatom such as azepinyl, and monocyclic 7 membered heteroaryl containing two heteroatoms such as 1 ,2-diazepinyl. </p><p id="p0048" num="0048">Examples of bicyclic 7-12 membered heteroaryl are bicyclic 9 membered heteroaryl containing one heteroatom such as indolyl, isoindolyl, indolizinyl, indolinyl, benzofuryl, isobenzofuryl, ben- zothiophenyl and isobenzothiophenyl, bicyclic 9 membered heteroaryl containing two heteroa- toms such as indazolyl, benzimidazolyl, benzimidazolinyl, benzoxazolyl, benzisooxazolyl, benzthiazolyl, benzisothiazolyl, furopyridyl and thienopyridyl, bicyclic 9 membered heteroaryl containing three heteroatoms such as benzotriazolyl, benzoxadiazolyl, oxazolopyridyl, isooxa- zolopyridyl, thiazolopyridyl, isothiazolopyridyl and imidazopyridyl, bicyclic 9 membered heteroaryl containing four heteroatoms such as purinyl, bicyclic 10 membered heteroaryl containing one heteroatom such as quinolyl, isoquinolyl, chromenyl and chromanyl, bicyclic 10 membered heteroaryl containing two heteroatoms such as quinoxalinyl, quinazolinyl, cinnolinyl, phthalaz- inyl, 1 ,5-naphthyridinyl and 1 ,8-naphthyridinyl, bicyclic 10 membered heteroaryl containing three heteroatoms such as pyridopyrazinyl, pyridopyrimidinyl and pyridopyridazinyl, and bicyclic 10 membered heteroaryl containing four heteroatoms such as pteridinyl. </p><p id="p0049" num="0049">Examples of tricyclic 9-14 membered heteroaryls are dibenzofuryl, acridinyl, phenoxazinyl, 7H- cyclopenta[1 ,2-b:3,4-b']dithiophenyl and 4H-cyclopenta[2,1 -b:3,4-b']dithiophenyl. </p><p id="p0050" num="0050">Examples of halogen are -F, -CI, -Br and -I. </p><p id="p0051" num="0051">Examples of Ci-10-alkoxy are methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, ferf-butoxy, n-pentoxy, neopentoxy, isopentoxy, hexoxy, n-heptoxy, n-octoxy, n-nonoxy and n-decoxy. Examples of C2-5-alkylene are ethylene, propylene, butylene and pentylene. 
<!-- EPO <DP n="11"/>-->
 Preferably, R<sup>1</sup> and R<sup>2</sup> are independently selected from the group consisting of H , Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, 3-14 membered cyclohetero- alkyl, wherein if R<sup>1</sup> or R<sup>2</sup> are Ci-30-alkyl, C2-3o-alkenyl or C2-3o-alkynyl, this R<sup>1</sup> or R<sup>2</sup> can be optionally substituted with 1 to 6 groups independently selected from the group consisting of halogen, -CN , -NO2, -OH , Ci-10-alkoxy, -O-CH<sub>2</sub>CH<sub>2</sub>O-Ci-i<sub>0</sub>-alkyl, -O-COR<sup>3</sup>, -S-Ci-10-alkyl, -N H<sub>2</sub>, -N H R<sup>3</sup>, -N R3R<sup>4</sup>, -N H-COR<sup>3</sup>, -COOH , -COOR<sup>3</sup>, -CON H2, -CO N H R<sup>3</sup>, -CON R<sup>3</sup>R<sup>4</sup>, -CO-H , -COR<sup>3</sup>,</p><p id="p0052" num="0052">C3-io-cycloalkyl, 3-14 membered cycloheteroalkyl, C6-i<sub>4</sub>-aryl and 5-14 membered heteroaryl; if R<sup>1</sup> or R<sup>2</sup> are C3-io-cycloalkyl, Cs-io-cycloalkenyl or 3-14 membered cycloheteroalkyl, this R<sup>1</sup> or R<sup>2</sup> can be optionally substituted with 1 to 6 groups independently selected from the group consisting of halogen, -CN , -NO2, -OH , Ci-10-alkoxy, -O-CH<sub>2</sub>CH<sub>2</sub>O-Ci-i<sub>0</sub>-alkyl, -O-COR<sup>3</sup>,</p><p id="p0053" num="0053">-S-Ci-10-alkyl, -N H<sub>2</sub>, -N H R<sup>3</sup>, -N R<sup>3</sup>R<sup>4</sup>, -N H-COR<sup>3</sup>, -COOH , -COOR<sup>3</sup>, -CON H2, -CO N H R<sup>3</sup>, -CON R<sup>3</sup>R<sup>4</sup>, -CO-H , -COR<sup>3</sup>, Ci-10-alkyl, C<sub>2</sub>-io-alkenyl, C<sub>2</sub>-io-alkynyl, C<sub>6</sub>-i<sub>4</sub>-aryl and 5-14 membered heteroaryl; wherein R<sup>3</sup> and R<sup>4</sup> are at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, 3-14 membered cycloheteroalkyl, C6-i<sub>4</sub>-aryl and 5-14 membered heteroaryl. </p><p id="p0054" num="0054">More preferably, R<sup>1</sup> and R<sup>2</sup> are independently selected from the group consisting of H , </p><p id="p0055" num="0055"> Ci-3o-alkyl, C<sub>2</sub>-3o-alkenyl, wherein if R<sup>1</sup> or R<sup>2</sup> are Ci-30-alkyl or C2-3o-alkenyl, this R<sup>1</sup> or R<sup>2</sup> can be optionally substituted with 1 to 6 groups independently selected from the group consisting of halogen, -CN , -NO2, -OH , Ci-10-alkoxy, -O-CH<sub>2</sub>CH<sub>2</sub>O-Ci-i<sub>0</sub>-alkyl, -O-COR<sup>3</sup>, -S-Ci-10-alkyl, -N H<sub>2</sub>, -N H R<sup>3</sup>, -N R<sup>3</sup>R<sup>4</sup>, -N H-COR<sup>3</sup>, -COOH , -COOR<sup>3</sup>, -CON H2, -CO N H R<sup>3</sup>, -CON R<sup>3</sup>R<sup>4</sup>, -CO-H , -COR<sup>3</sup>, C<sub>3</sub>-io-cyclo- alkyl, 3-14 membered cycloheteroalkyl, C6-i<sub>4</sub>-aryl and 5-14 membered heteroaryl; wherein R<sup>3</sup> and R<sup>4</sup> are at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, 3-14 membered cycloheteroalkyl, C6-i<sub>4</sub>-aryl and 5-14 membered heteroaryl. 
<!-- EPO <DP n="12"/>-->
 Even more preferably, R<sup>1</sup> and R<sup>2</sup> are independently from each other Ci-30-alkyl, wherein R<sup>1</sup> or R<sup>2</sup> can be optionally substituted with 1 to 6 groups independently selected from the group consisting of halogen, -CN , -NO2, -OH , Ci-10-alkoxy, -0-CH2CH<sub>2</sub>0-Ci-io-alkyl, -0-COR<sup>3</sup>, -S-Ci-io-alkyl, -N H<sub>2</sub>, -N H R<sup>3</sup>, -N R<sup>3</sup>R<sup>4</sup>, -N H-COR<sup>3</sup>, -COOH , -COOR<sup>3</sup>, -CON H2, -CON H R<sup>3</sup>, -CON R<sup>3</sup>R<sup>4</sup>, -CO-H , -COR<sup>3</sup>, C<sub>3</sub>-i<sub>0</sub>-cycloalkyl, 3-14 membered cycloheteroalkyl, C6-i4-aryl and 5-14 membered heteroaryl; wherein R<sup>3</sup> and R<sup>4</sup> are at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C<sub>3</sub>-io-cycloalkyl, C5-io-cycloalkenyl, 3-14 membered cycloheteroalkyl, C6-i4-aryl and 5-14 membered heteroaryl. </p><p id="p0056" num="0056">Most preferably, R<sup>1</sup> and R<sup>2</sup> are the same and are Ci-<sub>3</sub>o-alkyl, preferably C<sub>3</sub>-8-alkyl, wherein R<sup>1</sup> or R<sup>2</sup> can be optionally substituted with 1 to 6 groups independently selected from the group consisting of halogen, -CN , -NO2, -OH , Ci-10-alkoxy, -0-CH<sub>2</sub>CH<sub>2</sub>0-Ci-io-alkyl, -0-COR<sup>3</sup>, -S-Ci-io-alkyl, -N H<sub>2</sub>, -N H R<sup>3</sup>, -N R<sup>3</sup>R<sup>4</sup>, -N H-COR<sup>3</sup>, -COOH , -COOR<sup>3</sup>, -CON H2, -CON H R<sup>3</sup>, -CON R<sup>3</sup>R<sup>4</sup>, -CO-H , -COR<sup>3</sup>, C<sub>3</sub>-i<sub>0</sub>-cycloalkyl, 3-14 membered cycloheteroalkyl, C6-i4-aryl and 5-14 membered heteroaryl; wherein R<sup>3</sup> and R<sup>4</sup> are at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C<sub>3</sub>-io-cycloalkyl, C5-io-cycloalkenyl, 3-14 membered cycloheteroalkyl, C6-i4-aryl and 5-14 membered heteroaryl. </p><p id="p0057" num="0057">In particular, R<sup>1</sup> and R<sup>2</sup> are the same and are unsubstituted Ci-<sub>3</sub>o-alkyl, preferably unsubstituted C<sub>3</sub>-8-alkyl such as n-(1 -ethyl)propyl. 
<!-- EPO <DP n="13"/>-->
 Also part of the invention, is a process for the preparation of the compound of formula 1 </p><p id="p0058" num="0058"><img id="imgf000013_0001" he="49" wi="50" file="imgf000013_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 wherein R<sup>1</sup> and R<sup>2</sup> are as defined above, which process comprises the steps of </p><p id="p0059" num="0059"> (i) treating a compound of formula (2) with a boron-containing compound of formula (3) in the presence of a transition metal-containing catalyst to form a boron-containing compound of formula (4) </p><p id="p0060" num="0060"><img id="imgf000013_0002" he="56" wi="164" file="imgf000013_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0061" num="0061"> (2) (3) (4) </p><p id="p0062" num="0062">wherein R<sup>1</sup> and R<sup>2</sup> are as defined above, and L is a linking group, and </p><p id="p0063" num="0063">(ii) treating the boron-containing compound of formula (4) with a cyanide source in order to form the compound of formula (1 ). </p><p id="p0064" num="0064">L is preferably C2-5-alkylene, which can be optionally substituted with 1 to 6 Ci-10-alkyl groups. More preferably L is ethylene or propylene and is substituted with 2 to 4 methyl groups. 
<!-- EPO <DP n="14"/>-->
 The transition metal-containing catalyst can be an iridium-containing catalyst such as </p><p id="p0065" num="0065">[lr(cod)OMe]2, or, preferably, a ruthenium-containing catalyst, such as RuH<sub>2</sub>(CO)(PPh3)3. If the transition metal-containing catalyst is an iridium-containing catalyst, the first step can be performed in the presence of a base such as di-ferf-butylbipyridine. If the transition metal- containing catalyst is an iridium-containing catalyst, the first step is usually performed in a suitable organic solvent such as tetrahydrofuran or 1 ,4-dioxane. If the transition metal-containing catalyst is an iridium-containing catalyst, the first step is usually performed at elevated tempera- tures, such as at temperatures from 60 to 1 10 °C. In principal, if the transition metal-containing catalyst is an iridium-containing catalyst, the first step can be performed in analogy to the method described by C. W. Liskey; X. Liao; J. F. Hartwig in J. Am. Chem. Soc. 2010, 132, 1 1389-1 1391 , and by I. A. I. Mkhalid, J. H. Barnard, T. B. Marder, J. M. Murphy and J. F. Hart- wig in Chem. Rev. 2010, 110, 890-931 . </p><p id="p0066" num="0066">If the transition metal-containing catalyst is a ruthenium-containing catalyst, the first step is usually performed in a suitable organic solvent such as toluene, pinacolone and mesitylene or mixtures thereof. If the transition metal-containing catalyst is ruthenium-containing catalyst, the first step is usually performed at elevated temperatures, such as at temperatures from 120 to 160 °C. </p><p id="p0067" num="0067">In one embodiment, the cyanide source in step two can be tetra-Ci-io-alkylammoniumcyanide, tetra-Ci-io-alkylphosphoniumcyanide or hexa-Ci-io-alkylguanidiniumcyanide. </p><p id="p0068" num="0068">In a second embodiment, the cyanide source in step two can be Zn(CN)<sub>2</sub>. </p><p id="p0069" num="0069">The second step is usually performed in the presence of a base such as CsF and a copper reagent such as Cu(N0<sub>3</sub>)2. The second step is usually performed in a suitable solvent such as water, methanol and dioxane, or mixtures thereof. The second step is usually performed at elevated temperatures, such as at temperatures from 80 to 120 °C. </p><p id="p0070" num="0070">In principal, if the metal cyanide is Zn(CN)<sub>2</sub>, step two can be performed in analogy to the method described by C. W. Liskey; X. Liao; J. F. Hartwig in J. Am. Chem. Soc. 2010, 132, 1 1389-1 1391 . </p><p id="p0071" num="0071">The compounds of formulae (4) and (1 ) can be isolated by methods known in the art, such as column chromatography. </p><p id="p0072" num="0072">The compound of formula (2) can be obtained by methods known in the art, for example as described in the subsection titled "Synthesis" of F. Wurthner, Chem. Commun., 2004, 1564-1579. 
<!-- EPO <DP n="15"/>-->
 Also part of the invention are the compounds of formula </p><p id="p0073" num="0073"><img id="imgf000015_0001" he="55" wi="67" file="imgf000015_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0074" num="0074">wherein R<sup>1</sup>, R<sup>2</sup> and L are as defined above. </p><p id="p0075" num="0075">Also part of the present invention is an electronic device comprising the compound of formula (1 ) as semiconducting material. </p><p id="p0076" num="0076">Also part of the invention is the use of the compound of formula (1 ) as semiconducting material. </p><p id="p0077" num="0077">In Figure 1 the design of the bottom-gate organic field effect transistor of example 5 is shown. </p><p id="p0078" num="0078">In Figure 2 the drain current ISD [A] in relation to the gate voltage VSG [V] (top transfer curve) and the drain current ISD<sup>0 5</sup> [μΑ° <sup>5</sup>] in relation to the gate voltage VSG [V] (bottom transfer curve) for the bottom-gate organic field effect transistor of example 5 comprising compound 1 b as semiconducting material at a drain voltage VSD of 1 00 V is shown. </p><p id="p0079" num="0079">In Figure 3 the charge carrier mobility [cmWs] in relation to the gate voltage VSG [V] for the bottom-gate organic field effect transistor of example 5 comprising compound 1 b as semiconducting material is shown. </p><p id="p0080" num="0080">The compounds of formula (1 ) show a high charge carrier mobility and a high stability, in particular towards oxidation, under ambient conditions. Furthermore the compounds of formula (1 ) are compatible with liquid processing techniques. 
<!-- EPO <DP n="16"/>-->
 Examples </p><p id="p0081" num="0081">Example 1 </p><p id="p0082" num="0082"> Preparation of A/,/V'-bis(1 -ethylpropyl)-2,5,8,1 1 -tetrakis[4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2- y]perylene-3,4:9,10-tetracarboxylic acid bisimide (4a) </p><p id="p0083" num="0083"><img id="imgf000016_0001" he="79" wi="148" file="imgf000016_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0084" num="0084">A/,/V'-Bis(1 -ethylpropyl) perylene-3,4:9,10-tetracarboxylic acid bisimide (2a) (100 mg, 0,189 mmol) and bispinacolondiboronate (3a) (0,383 g, 1 ,51 mmol) are mixed together and dissolved in 2 mL dry mesitylene and 0,15 mL dry pinacolone. Argon is bubbled trough the solution for 30 minutes. RuH<sub>2</sub>(CO)(PPh3)3 (0,082 mg, 0,09 mmol) is added to the reaction mixture and the ves- sel heated to 140°C for 30 hours. After cooling the system to room temperature, the solvent is evaporated and the desired compound purified by column chromatography (silica, </p><p id="p0085" num="0085">CH<sub>2</sub>CI<sub>2</sub>/AcOEt 50/1 ). An orange bright solid is obtained with 60% yield (1 17 mg, 0,1 13 mmol). </p><p id="p0086" num="0086"><sup>1</sup>H NMR (250 MHz, CD<sub>2</sub>CI<sub>2</sub>) δ 8.59 (s, J = 7.3 Hz, 4H), 4.94 (tt, J = 9.2, 6.0 Hz, 2H), 2.33 - 2.10 (m, 4H), 2.04 - 1 .84 (m, 4H), 1 .51 (s, J = 7.2 Hz, 48H), 0.92 (t, J = 7.4 Hz, 12H). FD Mass Spectrum (8kV): m/z= 1033,33 (100%) [M+]. Absorption: 537 nm (in toluene). Emission: 548 nm (in toluene, exc 537 nm). Extinction Coefficient: 7,30 X 10<sup>4</sup> M <sup>1</sup>cm <sup>1</sup>. Fluorescence Quantum Yield: 0,89. Elemental Analysis: theoreticahC, 67.34; H, 7.21 ; N , 2.71 ;experimental: C, 67.29; H, 7.40; N, 2.96. 
<!-- EPO <DP n="17"/>-->
 Example 2 </p><p id="p0087" num="0087"> Preparation of A/,/V'-bis(1 -ethylpropyl)-2,5,8,1 1 -tetracarbonitrile-perylene-3,4:9,10-tetra- carboxylic acid bisimide (1a) </p><p id="p0088" num="0088"><img id="imgf000017_0001" he="66" wi="35" file="imgf000017_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0089" num="0089"> (1a) , '-Bis(1 -ethylpropyl)-2,5,8,1 1 -tetrakis[4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-y]pei len 3,4:9,10-tetracarboxylic acid bisimide (4a) (50 mg, 0,048 mmol), zinc cyanide (68 mg,0,58 mmol) caesium fluoride (29 mg, 0,19 mmol) and copper nitrate (90 mg, 0,38) are suspended in a mixture of water (1 ml_), methanol (1 ml.) and dioxane (1 ml_). The reaction vessel is closed and heated in microwave for 1 hour at 100 °C. The reaction mixture is then poured into a saturated solution of ammonium chloride and extracted with dichloromethane. The organic phase is dried over magnesium sulfate and the solvent evaporated. The product is purified via column chromatography (silica, dichloromethane/acetone 50/1 ) and obtained as a red-orange solid (yield 40%, 13 mg, 0,019 mmol). </p><p id="p0090" num="0090"><sup>1</sup>H NMR (250 MHz, CD<sub>2</sub>CI<sub>2</sub>) δ 8.98 (s, 4H), 5.09 (m, 2H), 2.38 - 2.16 (m, 4H), 2.1 1 - 1.90 (m, 4H), 0.96 (t, J = 7.5 Hz, 12H). FD Mass Spectrum (8kV): m/z= 630,9 (100%) [M+]. Absorption: 517 nm (in CH<sub>2</sub>CI<sub>2</sub>). Emission: 525 nm (in CH<sub>2</sub>CI<sub>2</sub>, exc 517 nm). Extinction Coefficient: 7,31 x 10<sup>4</sup> M-<sup>1</sup>cm-<sup>1</sup>. 
<!-- EPO <DP n="18"/>-->
 Example 3 </p><p id="p0091" num="0091"> Preparation of A/,/V'-bis(1 -heptyloctyl)-2,5,8,1 1 -tetrakis[4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2- y]perylene-3,4:9,10-tetracarboxylic acid bisimide (4b) </p><p id="p0092" num="0092"><img id="imgf000018_0001" he="115" wi="156" file="imgf000018_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0093" num="0093">A/,/V'-Bis(1 -heptyloctyl) perylene-3,4:9,10-tetracarboxylic acid bisimide (2b) (0,12 mmol) and bispinacolondiboronate (3a) (0.99mmol) are mixed together and dissolved in 2 ml. dry mesity- lene and 0,15 ml. dry pinacolone. Argon is bubbled trough the solution for 30 minutes. </p><p id="p0094" num="0094">RuH<sub>2</sub>(CO)(PPh<sub>3</sub>)3 (0.06 mmol) is added to the reaction mixture and the vessel heated to 140°C for 24 hours. After cooling the system to room temperature, the solvent is evaporated and the desired compound 4b is purified by column chromatography (silica, Ch C /AcOEt 50/1 ). 
<!-- EPO <DP n="19"/>-->
</p><p id="p0095" num="0095">Example 4 </p><p id="p0096" num="0096"> Preparation of A/,/V'-bis(1 -heptyloctyl)-2,5,8,1 1 -tetracyano-perylene-3,4:9,10-tetracarboxylic acid bisimide (1 b) </p><p id="p0097" num="0097"><img id="imgf000019_0001" he="101" wi="36" file="imgf000019_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0098" num="0098"> (1 b) ^'-Bis(1 -heptyloctyl)-2,5,8,1 1 -tetrakis[4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-y]perylene- 3,4:9,10-tetracarboxylic acid bisimide (4b) (63 mg, 0.05 mmol), prepared as described in exam- pie 3, cesium fluoride (29 mg, 0.19 mmol), zinc cyanide (68 mg, 0.58 mmol) and copper(ll) nitrate x 2.5 H2O (89 mg, 0.38 mmol) are suspended in 3 mL of a 5/1 mixture of dioxane/methanol and heated in a microwave vessel at 80 °C for 5 minutes. The reaction mixture is then poured in a saturated solution of ammonium chloride and extracted with dichloromethane. The organic phase is dried over magnesium sulfate and the solvent evaporated. The desired compound is obtained as a brownish solid after column chromatography (silica, dichloromethane) in 40% yield (18 mg, 0.019 mmol). 1 H NMR (500 MHz, CD2CI2) δ 8.99 (s, 4H), 5.25-5.14 (m, 2H), 2.30- 2.12 (m, 4H), 1.93 (m, 4H), 1.29 (m, 40H), 0.84 (t, J = 5.7 Hz, 12H). <sup>13</sup>C NMR (126 MHz, CD2CI2) δ 161 .33 (s), 133.20 (s), 131 .01 (s), 129.89 (s), 128.74 (s), 127.35 (s), 1 17.63 (s), 1 17.26 (s), 57.17 (s), 32.61 (s), 32.32 (s), 29.97 (s), 29.74 (s), 27.51 (s), 23.16 (s), 14.38 (s). FD/MS (8kV): m/z = 909.9 (100%) [M<sup>+</sup>]. UV-Vis (in dichloromethane, <sub>ma</sub>* (ε [M <sup>1</sup> cm <sup>1</sup>]: 518 nm (7.0 x 10<sup>4</sup> M <sup>1</sup> cm <sup>1</sup>). Fluorescence (in dichloromethane, λβχ = 528 nm. φ<sub>βχ</sub>: 0.55. Elem. Anal.: theoretical: C: 76.46%, H: 7.30%; N: 9.22%; experimental: C: 76.80%; H: 6.98%; N : 9.50%. 
<!-- EPO <DP n="20"/>-->
 Example 5 </p><p id="p0099" num="0099"> Preparation of bottom-gate organic field effect transistors containing compound 1 b as semiconducting material Thermally grown silicon dioxide (thickness: 200 nm) is used as dielectric layer. The gate electrode is formed by depositing highly doped silicon on one side of the dielectric layer. The other side of the dielectric layer is treated with hexamethyldisilazane (HMDS) by vapour deposition of hexamethyldisilazane. The contact angle of the surface of the HM PS-treated side of the dielectric layer is 93.2 ± 1.3°. Source/drain electrodes (Ta (thickness: 10 nm) covered by Au (thick- ness: 40 nm)) are deposited on the HM PS-treated side of the dielectric layer by vapour deposition. The channel length is 20 μιη and the channel width is 1.4 mm, affording W/L = 70. The source/drain electrodes are then covered with the semiconducting layer (thickness: ca. 100 nm) by drop-casting a solution of compound 1 b in chloroform (concentration = 10 mg/mL) in a nitrogen filled glove box (O2 content: 0.1 ppm, H<sub>2</sub>0 content: 0.0 ppm, pressure: 1 120 Pa, tempera- ture: 17 °C) using a Keithley 4200 machine. </p><p id="p0100" num="0100">The design of the bottom-gate organic field effect transistor of example 5 is shown in Figure 1 . </p><p id="p0101" num="0101">The drain current ISD [A] in relation to the gate voltage VSG [V] (top transfer curve) and the drain current ISD<sup>0 5</sup> [μΑ° <sup>5</sup>] in relation to the gate voltage VSG [V] (bottom transfer curve) for the bottom- gate organic field effect transistor of example 5 comprising compound 1 b as semiconducting material at a drain voltage VSD of 100 V is determined in a nitrogen filled glove box (O2 content: 0.1 ppm, H<sub>2</sub>0 content: 0.0 ppm, pressure: 1 120 Pa, temperature: 17 °C) using a Keithley 4200 machine is shown. The results are shown in Figure 2. </p><p id="p0102" num="0102">In Figure 3 the charge carrier mobility [cm s] in relation to the gate voltage VSG [V] for the bottom-gate organic field effect transistor of example 5 comprising compound 1 b as semiconducting material is shown. The average values and the 90% confidence interval (in parentheses) of the charge carrier mobility [cmWs], the ION/IOFF ratio and the switch-on voltage Vso [V] for the bottom-gate organic field effect transistor of example 5 comprising compound 1 b as semiconducting material is given in table 1. The switch-on voltage Vso [V] is the gate voltage VSG [V] where the drain current ISD [A] starts to increase (out of the off-state). </p><p id="p0103" num="0103"><img id="imgf000020_0001" he="20" wi="172" file="imgf000020_0001.tif" img-format="tif" img-content="table" orientation="portrait" inline="yes"/></p><p id="p0104" num="0104">Table 1 . 
</p></description><claims mxw-id="PCLM44852722" ref-ucid="WO-2012117089-A1" lang="EN" load-source="patent-office"><claim-statement><!-- EPO <DP n="21"/>--> Claims </claim-statement><claim id="clm-0001" num="1"><claim-text> <img id="imgf000021_0001" he="71" wi="116" file="imgf000021_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/> </claim-text><claim-text>wherein </claim-text><claim-text> R<sup>1</sup> and R<sup>2</sup>are independently selected from the group consisting of H, Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, 3-14 membered cycloheteroalkyl, C6-i<sub>4</sub>-aryl and 5-14 membered heteroaryl, wherein if R<sup>1</sup> or R<sup>2</sup> are Ci-30-alkyl, C2-3o-alkenyl or C2-3o-alkynyl, this R<sup>1</sup> or R<sup>2</sup> can be optionally substituted with 1 to 6 groups independently selected from the group consisting of halogen, -CN, -NO2, -OH, Ci-10-alkoxy, -O-CH<sub>2</sub>CH<sub>2</sub>O-Ci-i<sub>0</sub>-alkyl, -O-COR<sup>3</sup>, -S-Ci-io-alkyl, -NH<sub>2</sub>, -NHR<sup>3</sup>, -NR3R<sup>4</sup>, -NH-COR<sup>3</sup>, -COOH, -COOR<sup>3</sup>, -CONH2, -CO NHR<sup>3</sup>, -CONR<sup>3</sup>R<sup>4</sup>, -CO-H, -COR<sup>3</sup>, C3-io-cycloalkyl, 3-14 membered cycloheteroalkyl, C6-i<sub>4</sub>-aryl and 5-14 membered heteroaryl; if R<sup>1</sup> or R<sup>2</sup> are C3-io-cycloalkyl, Cs-io-cycloalkenyl or 3-14 membered cycloheteroalkyl, this R<sup>1</sup> or R<sup>2</sup> can be optionally substituted with 1 to 6 groups independently selected from the group consisting of halogen, -CN, -NO2, -OH, Ci-io-alkoxy, -O-CH<sub>2</sub>CH<sub>2</sub>O-Ci-i<sub>0</sub>-alkyl, -O-COR<sup>3</sup>, -S-Ci-io-alkyl, -NH<sub>2</sub>, -NHR<sup>3</sup>, -NR<sup>3</sup>R<sup>4</sup>, -NH-COR<sup>3</sup>, -COOH, -COOR<sup>3</sup>, -CONH2, -CO NHR<sup>3</sup>,</claim-text><claim-text>-CONR<sup>3</sup>R<sup>4</sup>, -CO-H, -COR<sup>3</sup>, Ci-io-alkyl, C<sub>2</sub>-io-alkenyl, C<sub>2</sub>-io-alkynyl, C<sub>6</sub>-i<sub>4</sub>-aryl and 5-14 membered heteroaryl; if R<sup>1</sup> or R<sup>2</sup> are C6-i<sub>4</sub>-aryl or 5-14 membered heteroaryl, this R<sup>1</sup> or R<sup>2</sup> can be optionally substi- tuted with 1 to 6 groups independently selected from the group consisting of halogen, -CN, -NO2, -OH, Ci-io-alkoxy, -O-CH<sub>2</sub>CH<sub>2</sub>O-Ci-i<sub>0</sub>-alkyl, -O-COR<sup>3</sup>, -S-Ci-io-alkyl, -NH<sub>2</sub>, -NHR<sup>3</sup>, -NR<sup>3</sup>R<sup>4</sup>, -NH-COR<sup>3</sup>, -COOH, -COOR<sup>3</sup>, -CONH2, -CO NHR<sup>3</sup>, -CONR<sup>3</sup>R<sup>4</sup>, -CO-H, -COR<sup>3</sup>, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl and 3-14 membered cycloheteroalkyl, <!-- EPO <DP n="22"/>--> wherein R<sup>3</sup> and R<sup>4</sup> are at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, C5-io-cycloalkenyl, 3-14 membered cycloheteroalkyl, C6-i4-aryl and 5-14 membered heteroaryl. </claim-text></claim><claim id="clm-0002" num="2"><claim-text>2. A process for the preparation of the compound of formula (1 ) of claim 1 , which process comprises the steps of </claim-text><claim-text> (i) treating a compound of formula (2) with a boron-containing compound of formula (3) in the presence of a transition metal-containing catalyst to form a boron-containing compound of formula (4) </claim-text><claim-text> <img id="imgf000022_0001" he="56" wi="164" file="imgf000022_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/> </claim-text><claim-text> (2) (3) (4) </claim-text><claim-text>wherein R<sup>1</sup> and R<sup>2</sup> are as defined in claim 1 , and L is a linking group, and (ii) treating the boron-containing compound of formula (4) with a cyanide source in order to form the compound of formula (1 ). </claim-text></claim><claim id="clm-0003" num="3"><claim-text>3. The process of claim 2, wherein in the compound of formula (4) L is C2-5-alkylene, which can be optionally substituted with 1 to 6 Ci-10-alkyl groups. </claim-text></claim><claim id="clm-0004" num="4"><claim-text>4. The process of claim 2 or claim 3, wherein the cyanide source in step (ii) is selected from the group consisting of tetra-Ci-io-alkylammoniumcyanide, tetra-Ci-io-alkylphosphoniumcyanide and hexa-Ci-io-alkylguanidiniumcyanide. </claim-text></claim><claim id="clm-0005" num="5"><claim-text>5. The process of claim 2 or claim 3, wherein the cyanide source in step (ii) is Zn(CN)2. <!-- EPO <DP n="23"/>--> </claim-text></claim><claim id="clm-0006" num="6"><claim-text>6. A compound of formula </claim-text><claim-text> <img id="imgf000023_0001" he="55" wi="48" file="imgf000023_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/> </claim-text><claim-text> (4) wherein R<sup>1</sup>, R<sup>2</sup> are as defined in claim 1 and L is as defined in claim 2 or claim 3. </claim-text></claim><claim id="clm-0007" num="7"><claim-text>7. An electronic device comprising the compound of formula (1 ) of claim 1 as semiconducting material. </claim-text></claim><claim id="clm-0008" num="8"><claim-text>8. Use of the compound of formula (1 ) of claim 1 as semiconducting material. </claim-text></claim></claims><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
